SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

FDA Accepts Humanetics IND Application for BIO 300 Injectable Suspension

Humanetics says it will initiate its planned clinical study, subject to an incomplete condition in the source text.

Related stories